Enrich Biosystems
PrivateLast Round
VC Round
Jun 15, 2022
Total Funding Raised
$320,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Enrich Biosystems is a biotechnology company that develops a microfluidics-free cell analysis and retrieval platform for therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enrich Biosystems Comparables
Compare Enrich Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cell Microsystems | 86% | |
| CellChorus | 82% | |
| Partillion Bioscience Corporation | 80% |
Enrich Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 15, 2022 | ||||
| Accelerator | Jul 29, 2021 | ||||
| Seed | Jul 15, 2020 |
Key People
Founding team and executive leadership
Enrich Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Seed |
| Elm Street Ventures | VC Round |
| BioTools Innovator | Accelerator |
| Boston Harbor Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 2358% MoM, reaching 1.4K.
- May 18, 2026
Monthly visitors increased 290% MoM, from 178 to 695.
Enrich Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Enrich Biosystems's valuation, stock price, and market status.
Is Enrich Biosystems a public or private company?
Enrich Biosystems is a private company.
What is the current stock price of Enrich Biosystems?
Enrich Biosystems is a private company with no public stock price. No recent secondary market data is available.
How much is Enrich Biosystems worth (valuation)?
Valuation information for Enrich Biosystems is not publicly available.
Can I buy Enrich Biosystems stock?
Enrich Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Enrich Biosystems's last funding round?
Enrich Biosystems's most recent funding round was VC Round on June 15, 2022.
Who are the main investors in Enrich Biosystems?
Key investors in Enrich Biosystems include Connecticut Innovations.
Will Enrich Biosystems IPO soon?
No public IPO plans have been announced for Enrich Biosystems.
How can I track Enrich Biosystems secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Enrich Biosystems's secondary market activity and sign up for updates.